These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15303518)

  • 1. Status of legislation on pharmaceutical reimportation.
    Palumbo FB
    Manag Care; 2004 Jun; 13(6 Suppl):3-6; discussion 12-3, 41-2. PubMed ID: 15303518
    [No Abstract]   [Full Text] [Related]  

  • 2. United States prescription drug crisis. Reimportation of Canadian prescription drugs is not the answer.
    Martin J
    J Leg Med; 2006 Dec; 27(4):477-92. PubMed ID: 17162683
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescription drug reimportation. Panacea or problem?
    Dalzell MD
    Manag Care; 2000 Dec; 9(12):22-7. PubMed ID: 11188358
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug marketing exclusivity under United States and European Union law.
    Junod V
    Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347
    [No Abstract]   [Full Text] [Related]  

  • 5. The final sampling regulations of the Prescription Drug Marketing Act are alive and well: is your sampling program compliant?
    Romanski JA
    Food Drug Law J; 2003; 58(4):649-60. PubMed ID: 15027455
    [No Abstract]   [Full Text] [Related]  

  • 6. Intellectual property law in Israel, and US and European objections: Market exclusivity vs. data exclusivity.
    Morag-Sela T; Cohn I; Kowalski TJ; Jarecki-Black J; Clyde-Watson Z
    Nat Biotechnol; 2004 Dec; 22(12):1591-2. PubMed ID: 15583670
    [No Abstract]   [Full Text] [Related]  

  • 7. Retail health clinics are rolling your way.
    Sullivan D
    Fam Pract Manag; 2006 May; 13(5):65-72. PubMed ID: 16736907
    [No Abstract]   [Full Text] [Related]  

  • 8. The future of telemedicine & its Faustian reliance on regulatory trade barriers for protection.
    McLean TR
    Health Matrix Clevel; 2006; 16(2):443-509. PubMed ID: 16948249
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceuticals: drug importation--2005. End of Year Issue Brief.
    Varma P; Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708457
    [No Abstract]   [Full Text] [Related]  

  • 10. The relevance of intellectual property laws to reimportation.
    Wagner WJ
    Manag Care; 2004 Jun; 13(6 Suppl):20-2; discussion 33-4, 41-2. PubMed ID: 15303523
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceuticals: drug importation.
    Seay M; Jones TM
    Issue Brief Health Policy Track Serv; 2007 Jan; ():1-15. PubMed ID: 17361466
    [No Abstract]   [Full Text] [Related]  

  • 12. Legalizing imported medicines will increase health and safety risks to American patients.
    Antony PT
    Mo Med; 2005; 102(5):430-3. PubMed ID: 16259390
    [No Abstract]   [Full Text] [Related]  

  • 13. When can a veterinarian import a foreign drug?
    Curry-Galvin E
    J Am Vet Med Assoc; 2005 Aug; 227(4):538-9. PubMed ID: 16117056
    [No Abstract]   [Full Text] [Related]  

  • 14. Should the patent system for new medicines be abolished?
    DiMasi JA; Grabowski HG
    Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
    [No Abstract]   [Full Text] [Related]  

  • 15. Federal legislation to limit bulk drug exports.
    Eggertson L
    CMAJ; 2005 Aug; 173(3):242. PubMed ID: 15994423
    [No Abstract]   [Full Text] [Related]  

  • 16. Veterinarian wins Senate seat: Senator Allard a small business advocate. Interview by the AVMA Governmental Relations Division staff.
    Allard W
    J Am Vet Med Assoc; 1997 Jan; 210(1):7-9. PubMed ID: 8977638
    [No Abstract]   [Full Text] [Related]  

  • 17. Branded drug reformulation: the next brand vs. generic antitrust battleground.
    Amoresano GV
    Food Drug Law J; 2007; 62(1):249-56. PubMed ID: 17444032
    [No Abstract]   [Full Text] [Related]  

  • 18. Risks, regulation, and rewards in new drug development in the United States.
    DiMasi JA
    Regul Toxicol Pharmacol; 1994 Apr; 19(2):228-35. PubMed ID: 8041920
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-18. PubMed ID: 18345557
    [No Abstract]   [Full Text] [Related]  

  • 20. Convenient Ambulatory Care--Promise, Pitfalls, and Policy.
    Chang JE; Brundage SC; Chokshi DA
    N Engl J Med; 2015 Jul; 373(4):382-8. PubMed ID: 26200985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.